Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.08 -0.17 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Xeris Biopharma Holdings (XERS) recorded Return on Capital Employed [ROCE] of 17.23% in Q2 2026, up 21.50 percentage points from -4.27% a year earlier and up 3.89 percentage points from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Xeris Biopharma Holdings reported Return on Capital Employed [ROCE] of 10.22%, up 25.34 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for four straight years, with a four-year change of +85.62 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -15.13% in FY2024 (+3.33 pp), -18.46% in FY2023 (+14.21 pp), -32.67% in FY2022 (+42.74 pp) and -75.41% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for 15 consecutive quarters, with an average year-over-year change of +14.44 percentage points over the last eight quarters.
  • The year-over-year gain in Return on Capital Employed [ROCE] has ranged between 1.27 percentage points (Q3 2024) and 50.23 percentage points (Q4 2022) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 13.34% (Q1 2026), 9.31% (Q4 2025) and 4.15% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Xeris Biopharma Holdings 1.58 Bn 1.14 Bn 79.59 Mn 17.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.23%
Mar 31, 2026 13.34%
Dec 31, 2025 9.31%
Sep 30, 2025 4.15%
Jun 30, 2025 -4.27%
Mar 31, 2025 -10.03%
Dec 31, 2024 -15.18%
Sep 30, 2024 -19.19%
Jun 30, 2024 -14.37%
Mar 31, 2024 -17.53%
Dec 31, 2023 -19.13%
Sep 30, 2023 -20.45%
Jun 30, 2023 -25.76%
Mar 31, 2023 -26.30%
Dec 31, 2022 -32.76%
Sep 30, 2022 -47.49%
Jun 30, 2022 -45.76%
Mar 31, 2022 -50.09%
Dec 31, 2021 -82.98%
API Access

Xeris Biopharma Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XERS&period=max&api_key=YOUR_API_KEY